Market Access World USA 2011- Speaker list

Dr. Aronson is the Executive Director of the Blue Cross and Blue Shield Association Technology Evaluation Center (TEC). She has overseen TEC's development as a nationally recognized technology assessment program and an Evidence-based Practice Center (EPC) of the...

Dr. Antje Behring graduated with a PharmD and PhD in pharmaceutical science from the University of Munich, Germany. After working as consulting pharmacist for a German health insurance company, she joined Germany’s Federal Joint Committee (Gemeinsamer Bundesausschuss)...

Elise Berliner, Ph.D., is the Director of the Technology Assessment Program at the Agency for Healthcare Research and Quality (AHRQ). The Technology Assessment program provides technology assessments to the Centers for Medicare & Medicaid Services (CMS) to inform...

Lon Castle originally joined Medco in January 2001. In May 2007 he became responsible for business opportunities and clinical innovation related to pharmacogenomics and personalized medicine. Dr. Castle has designed and developed numerous innovative...

Chester “Chip” Davis, Jr. currently serves as Executive Vice President for Advocacy at PhRMA. In this role Davis is responsible for leading and managing PhRMA’s federal, state and international government relations and advocacy efforts. A veteran of the...

Mary Grealy is president of the Healthcare Leadership Council, a coalition of chief executives of the nation’s leading healthcare companies and organizations. The HLC advocates consumer-centered healthcare reform, emphasizing the value of private sector innovation. It ...

Dean joined Novartis with significant experience in developing consensus among senior medical thought leaders, corporate executives and key stakeholders in health care. He does this by creating portfolio value based upon the incorporation of customer needs into...

Thomas L. Johnson serves as President and CEO of the Medicaid Health Plans of America, a Washington-DC-based trade association representing Medicaid health plans. Mr. Johnson is also the Founder and President of the MHPA Center for Best Practices. Mr. Johnson...

John Kaelin is Senior Vice President for Health Reform Implementation at UnitedHealthcare Community and State, a subsidiary of UnitedHealth Group. UHC Community and State health plans serve more than 3 million Medicaid, Children’s Health Insurance Program (CHIP) and...

Dr. Kim is currently Executive Director, Health Economics and Outcomes Research at Novartis Pharmaceuticals Corporation, leading a team supporting Neuroscience, Psychiatry, and Multiple Sclerosis products. He has also conducted outcomes research to support...

Dr. Klein is currently the Senior Director of Global Health Technology Assessment (HTA) and Customer Engagement for the Global Health Outcomes organization at Eli Lilly and Company. In this role Eric oversees all HTA and Outcomes Liaison work globally, with regional...

Chairman of the Executive Committee, European Network for Health Technology Assessment, EUnetHTA, and Director of its Coordinating Secretariat, National Board of Health, Denmark. Adjunct professor in health services research and health technology assessment at...

Michael Lauer, M.D., is the director of the Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). In this position, Dr. Lauer provides leadership for the Institute's national...

Sang Moo Lee MD, PhD is Executive director of Center for New Health Technology Assessment in NECA (National Evidence-based healthcare Collaborating Agency). His background is a clinician, and his major is internal medicine, and his sub-specialty is respiratory and...

Dr. Eleanor M. Perfetto joined Pfizer Inc in January 2006. In 2009, she became Senior Director, Reimbursement & Regulatory Affairs, Federal Government Relations. Dr. Perfetto monitors and analyzes prescription drug and healthcare coverage and reimbursement policy...

Steve Phillips is Director, Health Policy and Reimbursement with Johnson & Johnson’ corporate Government Affairs and Policy office. In this role, he provides leadership and guidance in the area of health policy to all J&J operating companies. Key areas of focus are:...

Dr. Pwu obtained her PhD from College of Public Health, National Taiwan University: and the subject of her dissertation was the application of cost-effective analysis using examples from vaccine and anti-viral treatments. Initially trained as an...

Ed Schoonveld is a Principal with ZS Associates in Princeton, NJ and Lead for the firm’s Market Access and Pricing Practice. He has extensive experience in pharmaceutical marketing and pricing from both the corporate pharma and consultancy perspective. He has gained...

Chuck is responsible for leading the Commercialization Strategy Group for PAREXEL, a global consulting practice designed to develop workable strategies to support patient access to therapy, including payer and market analyses, economic modeling, claims data...

Sripen Tantivess is a pharmacist by first degree, and have a PhD in Public Health and Policy from the London School of Hygiene and Tropical Medicine. She worked at Thailand’s Food and drug Administration as technical officer and program manager for almost 20...

Arnold van Halteren (1975) completed his MSc in Human Movement Sciences. In 2002, he joined the Health Care Insurance Board, the Dutch reimbursement agency. During the first years he specialized in operational and strategic issues in the assessment and appraisal of...

Mel D Walker BPharm MRPharmS PhD. Mel’s current role was specifically created to help GSK develop a deeper understanding of payer needs, through improved engagement with this diverse stakeholder group. In this capacity, he has taken a particular interest in...

Ken is currently a Senior Consultant in Bridgehead’s New York office. Ken joined Bridgehead over a year ago from Kantar Health in Maryland where he was a Vice President of their global market access consulting practice. Ken has over 10 years of experience in the...

Kelly Whitener works for the Senate Committee on Finance, managing the Medicaid, CHIP, and prevention and wellness portfolio. Kelly studied psychology and Spanish at the University of Michigan and earned a Masters of Public Health from UCLA. Kelly’s work has focused...